Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Bausch + Lomb Corporation, 3 years.
Bausch + Lomb Corporation
Director
Celularity Inc.
Director
TriSalus Life Sciences Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 7, 2026 | Bausch + Lomb Corporation | Open-market sale | −6,059 | $16.58 | $100,458 |
| Aug 6, 2026 | Bausch + Lomb Corporation | Open-market sale | −12,500 | $16.50 | $206,250 |
| May 26, 2026 | Bausch + Lomb Corporation | Grant or award | +15,842 | $15.78 | $249,987 |
| Feb 27, 2026 | Bausch + Lomb Corporation | Open-market purchase | +4,364 | $18.31 | $79,905 |
| Feb 27, 2026 | Bausch + Lomb Corporation | Grant or award | +4,364 | — | — |
| May 27, 2025 | Bausch + Lomb Corporation | Grant or award | +20,338 | — | — |
| May 2, 2025 | Bausch + Lomb Corporation | Open-market purchase | +1,695 | $11.76 | $19,933 |
| Aug 2, 2024 | Bausch + Lomb Corporation | Grant or award | +14,696 | — | — |
| Jun 14, 2023 | Celularity Inc. | Grant or award | +199,921 | — | — |
| May 4, 2023 | Bausch + Lomb Corporation | Grant or award | +12,857 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.